SOLV

BUY

Solventum Corporation

Healthcare · Rank #14 · Analyzed Apr 20, 2026

$70.48

Current Price

$71.04

Intrinsic Value

+62.5%

Upside/Downside

10/10

Score

3/5

Quality

Analysis Summary

Valuation Consensus2/3 methods agree

Quality Score3/5.0

Framework RatingBUY

Price vs Intrinsic ValueUndervalued by 62.5%

Fair Value Range

Low$23.30

Base (IV)$71.04

High$114.56

Entry Points

Conservative$23.30

Moderate$47.17

Aggressive$71.04

Quality & Moat Breakdown

Return on Equity38.9% → 1.0/1.0

Debt LevelD/E 104 → 0/1.0

Revenue QualityGrowth 5.8%, margin Δ-10.6% → 0.5/1.0

Moat Strength2.5/5 → 0.5/1.0

Profit Margins18.7% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods — Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation — with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.